Mauro Di Ianni Selected Research

Mauro Di Ianni Research Topics

Disease

9	Leukemia 06/2021 - 09/2002
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2019 - 07/2005
5	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 09/2002
4	Essential Thrombocythemia 01/2022 - 07/2008
4	Infections 09/2011 - 01/2008
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 02/2003
3	Venous Thromboembolism 11/2011 - 07/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2010
2	Neoplasms (Cancer) 04/2013 - 01/2004
2	Thrombosis (Thrombus) 11/2011 - 07/2008
2	Multiple Myeloma 09/2007 - 01/2004
1	Bronchiolitis Obliterans Syndrome 12/2017
1	Lymphadenopathy 11/2017
1	Iron Overload 07/2015
1	Hypoxia (Hypoxemia) 05/2014
1	GATA2 Deficiency 01/2013
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2013
1	Lymphoma (Lymphomas) 09/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2012
1	Hodgkin Disease (Hodgkin's Disease) 01/2012
1	Hemorrhage 11/2011
1	Aspergillosis 12/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2010
1	Pulmonary Embolism 01/2010
1	Pneumonia (Pneumonitis) 01/2010
1	Thrombocytopenia (Thrombopenia) 01/2010
1	Primary Myelofibrosis (Myelosclerosis) 01/2009
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2008
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 07/2008
1	Secondary Hyperparathyroidism 05/2007
1	Osteoporosis 05/2007
1	Metabolic Bone Diseases (Osteopenia) 05/2007

Drug/Important Bio-Agent (IBA)

2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2020
2	ibrutinibIBA 12/2019 - 11/2017
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 09/2012 - 01/2012
2	Carboplatin (JM8)FDA LinkGeneric 09/2012 - 01/2012
2	Etoposide (VP 16)FDA LinkGeneric 09/2012 - 01/2012
2	Biological ProductsIBA 11/2010 - 01/2007
2	Thymidine KinaseIBA 02/2003 - 09/2002
1	ThromboxanesIBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2019
1	Bepridil (Vascor)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Biological FactorsIBA 11/2017
1	Hemoglobins (Hemoglobin)IBA 11/2017
1	IronIBA 07/2015
1	Deferasirox FDA Link 07/2015
1	Chelating AgentsIBA 07/2015
1	MyoglobinIBA 05/2014
1	NeuroglobinIBA 05/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2014
1	NF-kappa B (NF-kB)IBA 08/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2013
1	benzyloxycarbonyl- leucyl- leucyl- norleucinalIBA 04/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	AnticoagulantsIBA 11/2011
1	Vitamin K FDA Link 11/2011
1	dectin 1IBA 12/2010
1	Codon (Codons)IBA 12/2010
1	NucleophosminIBA 11/2010
1	Heparin (Liquaemin)FDA LinkGeneric 01/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2009
1	Thalidomide (Thalomid)FDA Link 01/2009
1	NAD (NADH)IBA 11/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2008
1	Oxidoreductases (Dehydrogenase)IBA 11/2008
1	Oral ContraceptivesIBA 07/2008
1	Janus Kinase 2IBA 07/2008
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2007
1	Bone Density Conservation AgentsIBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2005
1	Melphalan (Alkeran)FDA LinkGeneric 01/2004
1	Busulfan (Busulfex)FDA Link 01/2004
1	Alemtuzumab (Campath)FDA Link 01/2004
1	Neomycin FDA LinkGeneric 02/2003
1	Ganciclovir (Cytovene)FDA LinkGeneric 09/2002

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2009
6	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2007
6	Stem Cell Transplantation 09/2012 - 01/2004
4	Haploidentical Transplantation 07/2014 - 01/2007
2	Transplantation 12/2020 - 12/2010
2	Drug Therapy (Chemotherapy) 09/2012 - 01/2004
1	Immunotherapy 06/2021